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The finding of striking elevation of the serum activity of glutamic-oxaloacetic 
transaminase (SGO-T) during the introductory clinical phase of acute infec- 
tious hepatitis  (1)  prompted  the present study of  the alterations  of  SGO-T 
during the course of mouse hepatitis. The purpose of this study was:  (a)  to 
ascertain the relationship, if any, between SGO-T and the  course of  experi- 
mental hepatitis; and (b) to determine whether there was any correlation be- 
tween the  SGO-T activity, the degree of viremia, and the histologic hepatic 
changes resulting from mouse hepatitis. 
Materials  and Methods 
Ft hybrids  of C58 X  BALB (F1) cross and Princeton Rockefeller Institute (PRI) mice 
were inoculated with a filtrate of the hepatitis virus which had been isolated from leukemic 
mice (2). 
At designated periods following  inoculations of the mice, groups of three animals were bled 
from the brachini artery in such a manner that muscle trauma was reduced to a minimum. 
A control group of untreated mice was bled at the same time. The SGO-T activity of each 
serum was determined and the average for the group of three was calculated. The virus con- 
tent was determined on the residual pooled blood of each of the groups. Similarly, the livers 
and spleens of each group were pooled, homogenized, and made up to 10 per cent in saline. 
The virus content of each mixture was determined. Sections of liver were obtained for histo- 
logic study. 
Weanling PRI mice are extremely sensitive to mouse hepatitis  (2) and were therefore used 
for the titration of virus content of material from infected mice. The LDb0 was calculated by 
the method of Reed and Muench (3). 
Serum glutamic-oxaloacetic transaminase (SGO-T) was determined spectrophotometrieally 
(4). One unit is designated as a change in optical density of 0.001/ml./minute  at wave length 
340 m#. The micromolar extinction coefficient  of DPNH2 is 2.05. The normal range of SGO-T 
for the mouse was 50 to 125 units per ml. serum. 
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RESULTS 
A group of PRI weanlings and a group of Fl adults were inoculated intraperitoneally  with 
0.I ml. of I0  -~ dilution of virus filtrate. At 8 hours, at 24 hours, and thereafter  at daily in- 
tervals, three mice in each group were bled and their livers and spleens collected as described 
under Methods. Virus titrations  were made of the viscera and of the blood; SGO-T activity 
was measured in the serum. Table I summarizes the data obtained from this experiment. 
The PRI mice showed an SGO-T peak on the 4th day, but could not be fol- 
lowed longer, since there were no survivors on the 5th day. There is an apparent 
relationship between the SGO-T activity and the level of the blood virus titer. 
TABLE I 
SGO-T Act~vily in Mire Inoculated lntrap~itoneally  with 0.1 ml. 10-~ 
Dilution of Hepatitis  Virus 
Virus titer  SGO-T activity 
Time after inocu- 
lation  Blood*  Liver and spleen*  Serums 
PRI  Fl  PRI  Ft 
8 hrs. 
24  " 
48  " 
72  " 
4 days 
•  5  " 
6  " 
7  " 
9  " 
11  " 
<1.0 
6.5 
3.0 
3.0 
6.0 
~1.0 
NV 
1.0 
3.0 
5.0 
3.0 
NV 
PRI  FI 
2.5  1.5 
4.5  4.5 
3.0  4.0 
5.0  5.5 
8.0  3.5 
--  3.0 
2.5 
<2.0 
--  NV 
¢¢ 
133 
130 
373 
2191 
3862 
units 
147 
103 
352 
627 
1816 
4366 
737 
193 
195 
142 
NV, no detectable virus. 
* Values of pooled samples from three animals. 
Average of three individual determinations. 
With  F1 mice, which are more resistant  to the disease than  the PRI mice, 
the  full  course  of mouse  hepatitis  was  observed  from the  time  of injection 
throughout  the  infection  and  into  the  recovery period.  The peak  of SGO-T 
activity was reached on the 5th day following virus inoculation and gradually 
returned toward normal during the ensuing 6 days. Again, in this instance the 
relationship  between  the  SGO-T  activity  and  the  virus  content  of blood  is 
apparent. 
Microscopic examination of the livers of the mice of both groups revealed no 
histological  abnormalities  24  hours  postinoculation.  In  the  PRI  mice  focal 
necrosis was apparent by the 2nd and 3rd days, and marked diffuse necrosis was 
present by the 4th day. In the F1 mice extensive and diffuse necrosis was seen 
on the 5th and 6th days. After this time most of the acutely ill mice had either 
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were beginning to recover and  in these anlmMs  areas  of focal necrosis were 
seen only occasionally. 
In an attempt to prolong the incubation period and diminish the severity of 
the infection, a more dilute virus inoculum was administered to F1 mice. In this 
experiment 0.1 ml. of 10  -4 dilution of mouse hepatitis was given intraperito- 
neaUy to each mouse. Generally, all the animals survived the infection with this 
reduced amount of virus despite considerable virus multiplication, as evidenced 
by high virus titers in the blood and livers and spleens during the first few days 
postinoculation. Table II summarizes the results of this experiment. The peak 
SGO-T was considerably lower, rising only to 520 units. Here again the rela- 
TABLE II 
SGO-T AcgrRy in FI Mice Inoculated Intraperitoneally wi~h 0.1 ml. 10  "a 
Dilution of Hepa~ilis Virus 
Time after inoculation 
24 hrs. 
48  " 
72  " 
4 days 
6  " 
7'  " 
9  " 
11  " 
Blood*  Liver and spleen* 
0.5 
4.5 
5.8 
6.0 
NV 
Virus titer 
4.0 
6.5 
5.0 
4.5 
2.0 
1.0 
NV 
SCK)-T activity 
Serum~ 
H~ 
103 
163 
236 
520 
316 
272 
125 
97 
99 
NV, no detectable virus. 
* Values of pooled samples from three animals. 
Average of three individual determinations. 
tionship between the blood virus titer and the SGO-T activity was apparent. 
Histological examination of the livers of these mice showed focal necrosis. The 
diffuse necrosis noted in the mice infected with the larger inoculum was not 
observed. The other organs and tissues of the mice showed no significant patho- 
logical lesions. It is of interest to note that regardless of whether the virus is 
administered intraperitoneaily or subcutaneously (5) the virus appears in the 
liver and spleen first and in greater quantity than in the serum. It is shortly 
after virus is released into the blood as a result of destruction of liver ceils that 
the SGO-T activity reaches a peak. 
If elevation of the SGO-T results from damage to fiver ceils permitting the 
escape of the enzyme into the blood stream, trauma to liver tissue should also 
result in an increase in the SGO-T. The following experiment was designed to 
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A group of mice, serving as controls, was subjected to a sham operation involving abdom- 
inal incision, manual manipulation of the liver, and closure of the abdominal incision. A second 
group of animals was subjected to the same procedure but in addition underwent left partial 
hepatectomy. 
No significant change in SGO-T activity was found after the sham operation, 
but partial hepatectomy resulted in an appreciable rise in SGO-T activity 24 
hours postoperatively with a  return toward normal activity in the ensuing  6 
days (Table III). A group of 50 unoperated mice had an average SGO-T ac- 
tivity of 115 units. 
TABLE  HI 
Ths E.ffect of Partial Hepatectomy and Sham Operation on SGO-T Actidty 
Partial hcpatectomy 
Sham operation 
Control 
Time after operation 
24 hrs. 
48  " 
72  " 
4 days 
5  " 
7  " 
24 hrs. 
48  " 
72  " 
SGO-T activity* 
Serum 
1722 
271 
254 
273 
195 
107 
120 
70 
80 
* Average of three individual determinations. 
:[ Average of determinations on fifty mice. 
DISCUSSION 
Glutamic-oxaloacetic transaminase  is widely distributed in animal  tissues. 
Although most concentrated in cardiac muscle,  the enzyme is present in con- 
siderable quantities in the liver (6). The sera of human beings and of all animals 
tested showed glutamic-oxaloacetic transaminase activity. The range of normal 
values appeared to be species specific, varying from 8 to 40 units in the human 
being, 100 to 375 units in the rat, and 50 to 125 units in the mouse per ml. of 
serum. 
Injury to cardiac muscle is followed by an increase in SGO-T activity which 
is proportional to the degree of heart cell damage (7). Simultaneously a decrease 
in  glutamic-oxaloacetic  transaminase  activity  was  found  in  the  infarcted 
muscle  (8).  This  suggests that  the rise  of SGO-T activity results from  the C.  FRIEND,  ]~.  WR6BLEWSKI,  AND  J.  S.  LA  DUE  7O3 
release of intracelluiar glutamic-oxaloacetic transaminase into the blood stream 
from the damaged heart muscle. Injury to liver tissue in rats by the instillation 
of carbon tetrachloride into the gastrointestinal  tract has been shown to cause 
a  rise in SGO-T that  is directly proportional  to the amount of carbon tetra- 
chloride given. Similarly, the degree of microscopic evidence of liver ceil injury 
was roughly proportional to the height of the SGO-T (9). 
In view of the observation that a marked rise in SGO-T occurred in patients 
with acute infectious hepatitis (1), the present study was undertaken to deter- 
mine whether  the same relationship  existed in mice with virus hepatitis.  Al- 
though mouse hepatitis  differs from human  infectious hepatitis,  especially in 
that  the incubation period and course of the disease are appreciably  shorter, 
the  qualitative  and  quantitative  changes  in  SGO-T  activity  appear  to  be 
comparable. 
The observations on mouse hepatitis herein reported suggest that liver cell 
injury due to virus hepatitis likewise results in an increase in SGO-T activity 
which  is roughly proportional  to  the  amount  of the  inoculum given,  to  the 
amount of the virus in the blood, and to the extent of histological necrosis of 
the  liver.  Increased  SGO-T  activity  following  partial  hepatectomy  in  mice 
suggests that  the SGO-T rises as a  result of release of intracelluiar  glutamic- 
oxaloacetic transaminase  from damaged  cells. Elevation  of SGO-T following 
partial hepatectomy in human beings has been reported  (1). It would appear, 
therefore, that in the experimental animals studied, toxic, infectious, or physi- 
cal  trauma  to  hepatic  tissue  results  in  increased  SGO-T  activity  which  is 
roughly proportional to the amount of liver cell injury. 
SUMMARY 
Experimental  infectious  mouse  hepatitis  is  associated  with  an  increase  in 
glutamic-oxaloacetic transaminase activity of the serum (SGO-T). 
A relationship  appears to exist between the rise in SGO-T activity and  (a) 
the size of the virus inoculum,  (b) the blood virus titer, and  (c) the degree of 
liver necrosis. 
Trauma to the liver following partial hepatectomy results in a rise in SGO-T 
activity in mice. 
Although  mouse  hepatitis  differs from  human  hepatitis  in  the  incubation 
period,  histological changes,  and  natural  course, both  infections bring  about 
comparable changes in SGO-T activity. 
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